GlassScriptPhysician profile
Darryl Prince
NPI 1851300362
$18,937.44
in general payments reported to CMS, 2019-2025
18 companies · $182 in 2025
The $182 reported for 2025 was less than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $395 · 2020: $2,371 · 2021: $11K · 2022: $4,709 · 2023: $392 · 2024: $247 · 2025: $182.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $785 · Education: $35.95.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $784.64 |
| Education | $35.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biohaven Pharmaceuticals, INC. | $12,386.95 | 2020-2021 | |
| Biohaven Pharmaceutical Holding Company LTD. | $4,708.93 | 2022 | |
| Tg Therapeutics, INC. | $545.66 | 2023-2025 | |
| Alnylam Pharmaceuticals INC. | $254.93 | 2021-2023 | Onpattro |
| Genentech USA, INC. | $229.59 | 2019 | |
| Biogen, INC. | $150.00 | 2021 | |
| Greenwich Biosciences, INC. | $148.62 | 2021 | |
| Acorda Therapeutics, INC | $137.71 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $100.80 | 2021 | |
| Celgene Corporation | $93.33 | 2021 | |
| Argenx US, INC. | $35.95 | 2023 | Vyvgart |
| Mdd US Operations, LLC | $27.82 | 2019 | |
| Pfizer INC. | $25.00 | 2024 | |
| Amgen INC. | $22.99 | 2024 | Uplizna |
| Acadia Pharmaceuticals INC | $22.79 | 2025 | Nuplazid |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $18.88 | 2025 | |
| Harmony Biosciences LLC | $14.24 | 2025 | |
| Abbvie INC. | $13.25 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Darryl Prince listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.